Heparin Sodium Fresenius 1 000 IU/1 ml. 5 000 IU/1 ml. 25 000 IU/1 ml Solution for injection
PDF Leaflet Revision Date: 27 March 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Anticoagulant for arterial and venous thrombosis treatment.
Dosage (summary)
IV: Initial 12,500 units, then 10,000 units every 4 hours; SC: 5,000 units every 8-12 hours for prophylaxis.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safer than warfarin in pregnancy; does not cross placenta or enter breast milk.
Key Drug Interactions
- Oral anticoagulants
- Aspirin
- NSAIDs
- Thrombolytics
Contraindications
- Hypersensitivity to heparin
- Active hemorrhage
- Severe hypertension
- Recent childbirth
Common side effects
- Haemorrhage
- Thrombocytopenia
- Hyperkalaemia
- Skin necrosis
Counselling Points
- Monitor for signs of bleeding
- Avoid IM injections
- Report any unusual bruising or bleeding
Serious warnings
- Risk of haemorrhage
- Thrombocytopenia monitoring required
- Caution in renal/hepatic impairment
Important Disclaimer
The Heparin Sodium Fresenius 1 000 IU/1 ml. 5 000 IU/1 ml. 25 000 IU/1 ml Solution for injection professional information leaflet below is the property of Fresenius Kabi Manufacturing Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
